Manjusha Hurry
Mississauga, ON L4Y1M4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Real-World Pattern of Treatment and Clinical Outcomes of EGFR-Mutant Non-Small Cell Lung Cancer in a Single Academic Centre in Quebec.
Journal: Current oncology (Toronto, Ont.)
Published: November 02, 2021
Examining Treatment Patterns and Real-World Outcomes in Chronic Lymphocytic Leukemia Using Administrative Data in Ontario.
Journal: Current oncology (Toronto, Ont.)
Published: October 08, 2021
Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data.
Journal: Journal of health economics and outcomes research
Published: September 10, 2021
A Population-based Study of Treatment Patterns and Survival of Patients With De Novo Stage IV Non-Small Cell Lung Cancer.
Journal: American journal of clinical oncology
Published: August 12, 2021
Understanding clinical practice and survival outcomes in patients with unresectable stage III non-small-cell lung cancer in a single centre in Quebec.
Journal: Current oncology (Toronto, Ont.)
Published: November 11, 2020
A reply to "Correspondence Re: Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model".
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 29, 2020
Retrospective cohort study of unresectable stage III non-small-cell lung cancer in Canada.
Journal: Current oncology (Toronto, Ont.)
Published: September 09, 2020
Real-world treatment patterns and survival in stage IV non-small-cell lung cancer in Canada.
Journal: Current oncology (Toronto, Ont.)
Published: September 09, 2020
Population-based Treatment Patterns and Outcomes for Stage III Non-Small Cell Lung Cancer Patients: A Real-world Evidence Study.
Journal: American journal of clinical oncology
Published: September 05, 2020
Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops.
Journal: International journal of technology assessment in health care
Published: May 20, 2020
Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancer.
Journal: Cancer medicine
Published: July 28, 2019
Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 22, 2019
Last Updated: 09/26/2026